Edgewell Personal Care Announces Third Quarter Fiscal 2025 Results
Edgewell Personal Care (NYSE: EPC) reported challenging Q3 fiscal 2025 results with declining performance. Net sales decreased 3.2% to $627.2 million, while organic net sales fell 4.2%. GAAP EPS dropped to $0.62 from $0.98, and adjusted EPS declined to $0.92 from $1.22 year-over-year.
The company faced significant headwinds in Sun Care seasons across North America and Latin America. Despite challenges, International business showed growth and improved market share. The company returned $31.7 million to shareholders through share repurchases ($24.5M) and dividends ($7.2M). Management updated full-year 2025 guidance, now expecting organic net sales to decrease approximately 1.3% and adjusted EPS of about $2.65.
Edgewell Personal Care (NYSE: EPC) ha riportato risultati difficili per il terzo trimestre fiscale 2025 con una performance in calo. Le vendite nette sono diminuite del 3,2% a 627,2 milioni di dollari, mentre le vendite nette organiche sono scese del 4,2%. L'EPS GAAP è sceso a 0,62 dollari da 0,98, e l'EPS rettificato è diminuito a 0,92 dollari da 1,22 anno su anno.
L'azienda ha affrontato significative difficoltà nelle stagioni di protezione solare in Nord America e America Latina. Nonostante le sfide, il business internazionale ha mostrato crescita e un miglioramento della quota di mercato. La società ha restituito 31,7 milioni di dollari agli azionisti attraverso riacquisti di azioni (24,5 milioni) e dividendi (7,2 milioni). La direzione ha aggiornato le previsioni per l'intero anno 2025, prevedendo ora una diminuzione delle vendite nette organiche di circa il 1,3% e un EPS rettificato di circa 2,65 dollari.
Edgewell Personal Care (NYSE: EPC) reportó resultados desafiantes en el tercer trimestre fiscal de 2025 con un desempeño a la baja. Las ventas netas disminuyeron un 3,2% hasta 627,2 millones de dólares, mientras que las ventas netas orgánicas cayeron un 4,2%. El EPS GAAP bajó a 0,62 dólares desde 0,98, y el EPS ajustado descendió a 0,92 dólares desde 1,22 año tras año.
La compañía enfrentó vientos en contra significativos en las temporadas de cuidado solar en Norteamérica y América Latina. A pesar de los desafíos, el negocio internacional mostró crecimiento y una mejora en la cuota de mercado. La empresa devolvió 31,7 millones de dólares a los accionistas mediante recompras de acciones (24,5 millones) y dividendos (7,2 millones). La dirección actualizó la guía para todo el año 2025, esperando ahora que las ventas netas orgánicas disminuyan aproximadamente un 1,3% y un EPS ajustado de alrededor de 2,65 dólares.
Edgewell Personal Care (NYSE: EPC)� 2025 회계연도 3분기 도전적인 실적� 보고하며 성과가 하락했습니다. 순매출은 3.2% 감소하여 6� 2,720� 달러� 기록했고, 유기� 순매출은 4.2% 감소했습니다. GAAP 주당순이�(EPS)은 전년 동기 0.98달러에서 0.62달러� 하락했으�, 조정 EPS� 1.22달러에서 0.92달러� 감소했습니다.
회사� 북미와 라틴 아메리카� 선케� 시즌에서 상당� 역풍� 맞았습니�. 어려움에도 불구하고 국제 사업은 성장하고 시장 점유율이 개선되었습니�. 회사� 자사� 매입(2,450� 달러)� 배당�(720� 달러)� 통해 � 3,170� 달러� 주주에게 환원했습니다. 경영진은 2025� 연간 가이던스를 업데이트하여, 유기� 순매출이 � 1.3% 감소하고 조정 EPS가 � 2.65달러가 � 것으� 예상하고 있습니다.
Edgewell Personal Care (NYSE : EPC) a publié des résultats difficiles pour le troisième trimestre de l'exercice 2025, avec une performance en baisse. Les ventes nettes ont diminué de 3,2 % à 627,2 millions de dollars, tandis que les ventes nettes organiques ont chuté de 4,2 %. Le BPA GAAP est passé de 0,98 à 0,62 dollar, et le BPA ajusté a diminué de 1,22 à 0,92 dollar d'une année sur l'autre.
L'entreprise a rencontré des vents contraires importants durant les saisons de soins solaires en Amérique du Nord et en Amérique latine. Malgré ces défis, l'activité internationale a connu une croissance et une amélioration de sa part de marché. La société a reversé 31,7 millions de dollars aux actionnaires via des rachats d'actions (24,5 millions) et des dividendes (7,2 millions). La direction a mis à jour ses prévisions pour l'année 2025, anticipant désormais une baisse des ventes nettes organiques d'environ 1,3 % et un BPA ajusté d'environ 2,65 dollars.
Edgewell Personal Care (NYSE: EPC) meldete herausfordernde Ergebnisse für das dritte Quartal des Geschäftsjahres 2025 mit rückläufiger Leistung. Der Nettoumsatz sank um 3,2% auf 627,2 Millionen US-Dollar, während der organische Nettoumsatz um 4,2% zurückging. Das GAAP-Ergebnis je Aktie (EPS) fiel von 0,98 auf 0,62 US-Dollar, und das bereinigte EPS sank von 1,22 auf 0,92 US-Dollar im Jahresvergleich.
Das Unternehmen sah sich in den Sun Care-Saisons in Nord- und Lateinamerika erheblichen Gegenwinden ausgesetzt. Trotz der Herausforderungen zeigte das internationale Geschäft Wachstum und eine verbesserte Marktanteile. Das Unternehmen gab 31,7 Millionen US-Dollar an die Aktionäre zurück durch Aktienrückkäufe (24,5 Mio. USD) und Dividenden (7,2 Mio. USD). Das Management aktualisierte die Prognose für das Gesamtjahr 2025 und erwartet nun einen Rückgang des organischen Nettoumsatzes um etwa 1,3% und ein bereinigtes EPS von etwa 2,65 US-Dollar.
- International business showed growth and strengthened market share position
- Returned $31.7 million to shareholders through dividends and share repurchases
- Strong supply chain execution led to productivity gains of 270-basis points
- Improved market share in Hawaiian Tropic, Cremo, and Hydro Silk brands
- Maintained solid liquidity with $199.6 million cash and $289.9 million credit facility available
- Net sales decreased 3.2% to $627.2 million, with organic sales down 4.2%
- GAAP EPS declined 36.7% to $0.62 from $0.98 year-over-year
- Adjusted gross margin decreased 150-basis points to 42.8%
- North America organic sales declined 8.0% due to volume declines and increased promotional levels
- Net debt leverage ratio increased to 3.7x
- Lowered full-year guidance with organic sales now expected to decrease 1.3%
- Free cash flow guidance reduced to $80 million from previous $130-140 million range
Insights
EPC's Q3 shows declining sales, reduced profitability, and lowered guidance amid challenging conditions in core markets.
Edgewell Personal Care posted disappointing Q3 results with net sales declining
Profitability metrics deteriorated across the board. Adjusted gross margin contracted
The company's liquidity position remains adequate with
Management has reduced full-year guidance substantially, now expecting organic sales to decline
By segment, Wet Shave showed relative resilience with only a
Net Sales
GAAP EPS
Updates Full Year Outlook
Executive Summary
- Net sales were
, a decrease of$627.2 million 3.2% compared to the prior year quarter. - Organic net sales decreased
4.2% (Organic basis excludes the impact from currency movements.) - GAAP Diluted Net Earnings Per Share ("EPS") were
, compared to$0.62 in the prior year quarter.$0.98 - Adjusted EPS were
, compared to$0.92 in the prior year quarter.$1.22 - Ended the third quarter with
in cash on hand, access to an additional$199.6 million under the Company's$289.9 million U.S. revolving credit facility available and a net debt leverage ratio of 3.7x. - Returned
to shareholders in the form of$31.7 million in share repurchases and$24.5 million of dividends in the third quarter.$7.2 million - The Board of Directors declared a cash dividend of
per common share on August 5, 2025 for the third quarter.$0.15
The Company reports and forecasts results on a GAAP and non-GAAP basis and has reconciled non-GAAP results and outlook to the most directly comparable GAAP measures later in this release. See non-GAAP Financial Measures for a more detailed explanation, including definitions of various non-GAAP terms used in this release. All comparisons used in this release are for the same period in the prior fiscal year unless otherwise stated.
"This was a challenging quarter, with our top and bottom-line performance falling below expectations, significantly impacted by very weak Sun Care seasons in
"Despite these transitory headwinds, we continued strong performance in our International business with growth and strengthened market share, and strong supply chain execution led to further productivity gains. Importantly, in
Fiscal 3Q 2025 Operating Results (Unaudited)
Net saleswere
Gross profitwas
Advertising and sales promotion expense ("A&P")was
Selling, general and administrative expense ("SG&A")was
The Company recorded pre-tax restructuring and related charges in support of cost efficiency and effectiveness programs of
Operating income, was
Interest expense associated with debtwas
Other (income) expense, net was income of
The effective tax rate for the first nine months of fiscal 2025 was
GAAP net earnings were
Net cash provided by operating activitieswas
Capital Allocation
On August 5, 2025, the Board of Directors declared a quarterly cash dividend of
Fiscal 3Q 2025 Operating Segment Results (Unaudited)
Wet Shave (Men's Systems, Women's Systems, Disposables, and Shave Preps)
Net sales increased
Sun and Skin Care (Sun Care, Men's and Women's Grooming Products, and Wet Ones)
Net sales decreased
Feminine Care (Tampons, Pads, and Liners)
Net sales decreased
Full Fiscal Year 2025 Financial Outlook
The Company is providing the following outlook assumptions for fiscal 2025*
- Organic net sales are now expected to decrease approximately
1.3% (previously in the range of flat to1% )- Currency is now expected to positively impact reported net sales by 10-basis points (previously, 10-basis points negative)
- GAAP EPS is now expected to be approximately
(previously in the range of$1.73 to$2.09 )$2.29 - Includes: Restructuring and re-positioning charges**, Sun Care reformulation, Other costs
- Adjusted EPS is now expected to be approximately
(previously in the range of$2.65 to$2.85 )$3.05 - Includes an estimated
per share unfavorable impact from foreign currency changes (previously$0.46 )$0.35 - Adjusted gross margin is expected to decrease approximately 60-basis points (previously increase 10-basis points), or increase 30-basis points (previously 70-basis points) at constant currency, primarily reflecting increased promotional levels, increased tariff impact, unfavorable mix, and incremental transactional currency headwinds.
- Adjusted operating margin is expected to decrease approximately 150 basis points (previously decrease 65-basis points), or 60 basis points at constant currency (previously decrease 10 basis points)
- The EPS outlook reflects the impact of expected share repurchases of approximately
$90 million
- Includes an estimated
- Adjusted EBITDA is expected to be approximately
(previously in the range of$312 million to$329 )$341 million - Includes an estimated
unfavorable (previously$29 million unfavorable) impact from foreign currency changes$22 million
- Includes an estimated
- Other Expense (Income), net is now expected to be expense of
(previously expense of$2 million ), inclusive of interest income of$3 million $2 million - Interest expense associated with debt is expected to be approximately
(previously$76 million )$74 million - Adjusted effective tax rate is expected to be approximately
16.5% (previously20% ) - Total depreciation and amortization expense expected to be approximately
(previously$88 million )$87 million - Capital expenditures expected to be approximately
2.5% to3.0% of net sales - Free cash flow is expected to be approximately
(previously in the range of$80 million to$130 million )$140 million
* This outlook reflects all known tariffs, including tariffs placed by the
** In fiscal 2025, the Company is taking specific actions to strengthen its operating model, simplify the organization and improve manufacturing and supply chain efficiency through restructuring and repositioning actions, including the organizational and operational changes in
Webcast Information
In conjunction with this announcement, the Company will hold an investor conference call beginning at 8:00 a.m. Eastern Time today. All interested parties may access a live webcast of this conference call at , under the "Investors," and "News and Events" tabs or by using the following link:
For those unable to participate during the live webcast, a re-play will be available on , under the "Investors," "Financial Reports," and "Quarterly Earnings" tabs. This release includes references to the Company's website and references to additional information and materials found on its website. The Company's website and such information and materials are not incorporated by reference in, and are not part of, this release.
About Edgewell
Edgewell is a leading pure-play consumer products company with an attractive, diversified portfolio of established brand names such as Schick®, Wilkinson Sword® and Billie® men's and women's shaving systems and disposable razors; Edge and Skintimate® shave preparations; Playtex®, Stayfree®, Carefree® and o.b.® feminine care products; Banana Boat®, Hawaiian Tropic®, Bulldog®, Jack Black®, and CREMO® sun and skin care products; and Wet Ones® products. The Company has a broad global footprint and operates in more than 50 markets, including the
Forward-Looking Statements. This document contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. You should not place undue reliance on these statements. Forward-looking statements generally can be identified by the use of words or phrases such as "believe," "expect," "expectation," "anticipate," "may," "could," "intend," "belief," "estimate," "plan," "target," "predict," "likely," "will," "should," "forecast," "outlook," or other similar words or phrases. These statements are not based on historical facts, but instead reflect the Company's expectations, estimates or projections concerning future results or events, including, without limitation, the future earnings and performance of Edgewell or any of its businesses. Many factors outside our control could affect the realization of these estimates. These statements are not guarantees of performance and are inherently subject to known and unknown risks, uncertainties and assumptions that are difficult to predict and could cause the Company's actual results to differ materially from those indicated by those statements. The Company cannot assure you that any of its expectations, estimates or projections will be achieved. The forward-looking statements included in this document are only made as of the date of this document and the Company disclaims any obligation to publicly update any forward-looking statement to reflect subsequent events or circumstances, except as required by law. You should not place undue reliance on these statements.
In addition, other risks and uncertainties not presently known to the Company or that it presently considers immaterial could significantly affect the accuracy of any such forward-looking statements. Risks and uncertainties include those detailed from time to time in the Company's publicly filed documents, including in Item 1A. Risk Factors of Part I of the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") on November 14, 2024 and in Item 1A. Risk Factors of Part II of the Company's Quarterly Report on Form 10-Q filed with the SEC on May 7, 2025.
Non-GAAP Financial Measures. While the Company reports financial results in accordance with generally accepted accounting principles ("GAAP") in the
This non-GAAP information is provided as a supplement to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. The Company uses this non-GAAP information internally to make operating decisions and believes it is helpful to investors because it allows more meaningful period-to-period comparisons of ongoing operating results. The information can also be used to perform analysis and to better identify operating trends that may otherwise be masked or distorted by the types of items that are excluded. This non-GAAP information is a component in determining management's incentive compensation. Finally, the Company believes this information provides a higher degree of transparency. The following provides additional detail on the Company's non-GAAP measures:
- The Company utilizes "adjusted" non-GAAP measures including gross margin, SG&A, operating income, operating margin, effective tax rate, net earnings, earnings per share, EBITDA, and other (income) expense to internally make operating decisions.
- Constant currency measures are calculated by removing the impact of translational and transactional foreign currencies changes, net of foreign currency hedges compared to the prior year. Transactional foreign currency changes are driven by foreign legal entities' transactions not denominated in local currency.
- The Company analyzes its net sales and segment profit on an organic basis to better measure the comparability of results between periods. Organic net sales and organic segment profit exclude the impact of changes in foreign currency and the impact of acquisitions.
- Segment profit will be impacted by fluctuations in translation and transactional foreign currency. The impact of currency was applied to segments using management's best estimate.
- Free cash flow is defined as net cash from operating activities, less capital expenditures plus collections of deferred purchase price of accounts receivable sold and proceeds from sales of fixed assets. Free cash flow conversion is defined as free cash flow as a percentage of net earnings adjusted for the net impact of non-cash impairments.
- Net debt is defined as Gross debt less cash. Net debt leverage ratio is defined as net debt divided by trailing twelve month adjusted EBITDA.
Basis of Presentation. Please refer to the Annual Report on Form 10-K filed with the SEC on November 14, 2024, as amended by the Company on November 21, 2024.
EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (unaudited, in millions, except per share data) | |||||||
Three Months Ended June 30, | Nine Months Ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net sales | $ 627.2 | $ 647.8 | $ 1,686.3 | $ 1,736.1 | |||
Cost of products sold | 358.7 | 360.7 | 970.0 | 993.2 | |||
Gross profit | 268.5 | 287.1 | 716.3 | 742.9 | |||
Selling, general and administrative expense | 104.4 | 110.1 | 313.0 | 320.9 | |||
Advertising and sales promotion expense | 80.4 | 76.6 | 196.2 | 187.9 | |||
Research and development expense | 14.0 | 14.6 | 41.8 | 42.1 | |||
Restructuring charges | 16.0 | 3.1 | 32.4 | 13.1 | |||
Operating income | 53.7 | 82.7 | 132.9 | 178.9 | |||
Interest expense associated with debt | 19.4 | 18.8 | 58.4 | 59.0 | |||
Other (income) expense, net | (2.9) | 1.4 | (2.3) | 4.4 | |||
Earnings before income taxes | 37.2 | 62.5 | 76.8 | 115.5 | |||
Income tax provision | 8.1 | 13.5 | 20.8 | 25.7 | |||
Net earnings | $ 29.1 | $ 49.0 | $ 56.0 | $ 89.8 | |||
Earnings per share: | |||||||
Basic net earnings per share | $ 0.62 | $ 0.99 | $ 1.17 | $ 1.80 | |||
Diluted net earnings per share | $ 0.62 | $ 0.98 | $ 1.17 | $ 1.79 | |||
Weighted-average shares outstanding: | |||||||
Basic | 46.8 | 49.5 | 47.8 | 49.8 | |||
Diluted | 47.0 | 50.1 | 48.0 | 50.3 | |||
See Accompanying Notes. |
EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited, in millions)
| |||
June 30, | September 30, | ||
Assets | |||
Current assets | |||
Cash and cash equivalents | $ 199.6 | $ 209.1 | |
Trade receivables, less allowance for doubtful accounts | 153.2 | 109.4 | |
Inventories | 488.4 | 477.3 | |
Other current assets | 163.5 | 140.2 | |
Total current assets | 1,004.7 | 936.0 | |
Property, plant and equipment, net | 355.7 | 349.1 | |
Goodwill | 1,342.9 | 1,338.6 | |
Other intangible assets, net | 929.3 | 948.5 | |
Other assets | 160.7 | 158.7 | |
Total assets | $ 3,793.3 | $ 3,730.9 | |
Liabilities and Shareholders' Equity | |||
Current liabilities | |||
Notes payable | $ 23.2 | $ 24.5 | |
Accounts payable | 224.5 | 219.3 | |
Other current liabilities | 319.7 | 319.8 | |
Total current liabilities | 567.4 | 563.6 | |
Long-term debt | 1,372.7 | 1,275.0 | |
Deferred income tax liabilities | 133.7 | 133.2 | |
Other liabilities | 151.5 | 175.0 | |
Total liabilities | 2,225.3 | 2,146.8 | |
Shareholders' equity | |||
Common shares | 0.7 | 0.7 | |
Additional paid-in capital | 1,573.5 | 1,586.0 | |
Retained earnings | 1,124.4 | 1,090.1 | |
Common shares in treasury at cost | (1,003.7) | (937.9) | |
Accumulated other comprehensive loss | (126.9) | (154.8) | |
Total shareholders' equity | 1,568.0 | 1,584.1 | |
Total liabilities and shareholders' equity | $ 3,793.3 | $ 3,730.9 | |
See Accompanying Notes. |
EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited, in millions) | |||
Nine Months Ended | |||
2025 | 2024 | ||
Cash Flow from Operating Activities | |||
Net earnings | $ 56.0 | $ 89.8 | |
Depreciation and amortization | 65.6 | 66.6 | |
Share-based compensation expense | 18.8 | 20.4 | |
Loss on sale of assets | 1.7 | 0.3 | |
Deferred compensation payments | (2.4) | (1.6) | |
Deferred income taxes | (0.5) | 1.3 | |
Other, net | (12.2) | (11.0) | |
Changes in current assets and liabilities used in operations | (82.7) | (8.5) | |
Net cash provided by operating activities | $ 44.3 | $ 157.3 | |
Cash Flow from Investing Activities | |||
Capital expenditures | $ (49.4) | $ (30.6) | |
Collection of deferred purchase price on accounts receivable sold | 5.6 | 0.2 | |
Other, net | (1.5) | (6.5) | |
Net cash used for investing activities | $ (45.3) | $ (36.9) | |
Cash Flow from Financing Activities | |||
Cash proceeds from debt with original maturities greater than 90 days | $ 774.0 | $ 633.0 | |
Cash payments on debt with original maturities greater than 90 days | (678.0) | (705.0) | |
(Payments for) proceeds from debt with original maturities of 90 days or less | (0.8) | 1.9 | |
Repurchase of shares | (90.2) | (40.2) | |
Dividends to common shareholders | (22.4) | (23.3) | |
Net financing inflow from the Accounts Receivable Facility | 14.2 | 4.3 | |
Employee shares withheld for taxes | (7.4) | (7.1) | |
Other, net | (0.3) | (2.9) | |
Net cash used for financing activities | $ (10.9) | $ (139.3) | |
Effect of exchange rate changes on cash | 2.4 | (1.4) | |
Net decrease in cash and cash equivalents | (9.5) | (20.3) | |
Cash and cash equivalents, beginning of period | 209.1 | 216.4 | |
Cash and cash equivalents, end of period | $ 199.6 | $ 196.1 | |
See Accompanying Notes. |
EDGEWELL PERSONAL CARE COMPANY
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited, in millions, except per share data)
Note 1 —� Segments
The Company conducts its business in the following three segments: Wet Shave, Sun and Skin Care, and Feminine Care (collectively, the "Segments," and each individually, a "Segment"). Segment performance is evaluated based on segment profit, exclusive of general corporate expenses, share-based compensation costs, items which are considered by the Company to be unusual or non-recurring and which may have a disproportionate positive or negative impact on the Company's financial results in any particular period and the amortization of intangible assets. Financial items, such as interest income and expense, are managed on a global basis at the corporate level. The exclusion of such charges from segment results reflects management's view on how it evaluates segment performance.
Segment net sales and profitability are presented below:
Three Months Ended | Nine Months Ended | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net Sales | |||||||
Wet Shave | $ 317.0 | $ 316.3 | $ 897.0 | $ 911.1 | |||
Sun and Skin Care | 243.4 | 256.9 | 595.1 | 608.1 | |||
Feminine Care | 66.8 | 74.6 | 194.2 | 216.9 | |||
Total net sales | $ 627.2 | $ 647.8 | $ 1,686.3 | $ 1,736.1 | |||
Segment Profit | |||||||
Wet Shave | $ 44.1 | $ 47.6 | $ 137.3 | $ 141.7 | |||
Sun and Skin Care | 46.0 | 64.2 | 93.4 | 117.3 | |||
Feminine Care | 4.5 | 6.6 | 10.8 | 22.6 | |||
Total segment profit | 94.6 | 118.4 | 241.5 | 281.6 | |||
General corporate and other expenses | (11.6) | (15.8) | (39.3) | (47.0) | |||
Amortization of intangibles | (7.8) | (7.7) | (23.3) | (23.3) | |||
Interest and other expense, net | (19.3) | (17.2) | (58.6) | (60.4) | |||
Restructuring and related charges | (17.8) | (3.2) | (34.2) | (13.2) | |||
Acquisition and integration costs | � | (0.7) | (0.5) | (2.1) | |||
Sun Care reformulation costs | (0.5) | (1.3) | (2.2) | (2.2) | |||
Wet Ones manufacturing plant fire | � | (2.7) | � | (8.0) | |||
Legal matters | � | (2.5) | � | (3.9) | |||
Gain on investment | � | (3.1) | 0.9 | (3.1) | |||
Commercial realignment | 0.1 | � | (3.0) | � | |||
Vendor bankruptcy | (1.2) | � | (1.6) | � | |||
Other project and related costs | 0.7 | (1.7) | (2.9) | (2.9) | |||
Total earnings before income taxes | $ 37.2 | $ 62.5 | $ 76.8 | $ 115.5 |
Refer to Note 2 - GAAP to Non-GAAP Reconciliations below for the income statement location of non-GAAP adjustments to earnings before income taxes.
Note 2 � GAAP to Non-GAAP Reconciliations
The following tables provide a GAAP to Non-GAAP reconciliation of certain line items from the Condensed Consolidated Statement of Earnings:
Three Months Ended June 30, 2025 | |||||||||||||
Gross | SG&A | Operating | EBIT (1) | Income | Net | Diluted EPS | |||||||
GAAP � Reported | $ 268.5 | $ 104.4 | $ 53.7 | $ 37.2 | $ 8.1 | $ 29.1 | $ 0.62 | ||||||
Restructuring and related charges | 1.2 | (0.6) | 17.8 | 17.8 | 4.4 | 13.4 | 0.28 | ||||||
Sun Care reformulation costs | � | � | 0.5 | 0.5 | 0.1 | 0.4 | 0.01 | ||||||
Commercial realignment | (0.1) | � | (0.1) | (0.1) | � | (0.1) | � | ||||||
Vendor bankruptcy | 1.2 | � | 1.2 | 1.2 | 0.3 | 0.9 | 0.02 | ||||||
Other project and related costs | � | (2.0) | 2.0 | (0.7) | (0.4) | (0.3) | (0.01) | ||||||
Total Adjusted Non-GAAP | $ 270.8 | $ 101.8 | $ 75.1 | $ 55.9 | $ 12.5 | $ 43.4 | $ 0.92 | ||||||
Adjusted Non-GAAP Constant Currency | $ 1.04 | ||||||||||||
GAAP as a percent of net sales | 42.8% | 16.6% | 8.6% | GAAP effective tax rate | 21.7% | ||||||||
Adjusted as a percent of net sales | 43.2% | 16.2% | 12.0% | Adjusted effective tax rate | 22.4% | ||||||||
Adjusted Constant Currency as a percent of net sales | 44.3% | 13.0% |
Three Months Ended June 30, 2024 | |||||||||||||
Gross | SG&A | Operating | EBIT (1) | Income | Net | Diluted EPS | |||||||
GAAP � Reported | $ 287.1 | $ 110.1 | $ 82.7 | $ 62.5 | $ 13.5 | $ 49.0 | $ 0.98 | ||||||
Restructuring and related charges | � | (0.1) | 3.2 | 3.2 | 0.8 | 2.4 | 0.04 | ||||||
Acquisition and integration costs | � | (0.7) | 0.7 | 0.7 | 0.2 | 0.5 | 0.01 | ||||||
Sun Care reformulation costs | � | � | 1.3 | 1.3 | 0.3 | 1.0 | 0.02 | ||||||
Wet Ones manufacturing plant fire | 2.7 | � | 2.7 | 2.7 | 0.7 | 2.0 | 0.04 | ||||||
Legal matter | � | (2.5) | 2.5 | 2.5 | 0.7 | 1.8 | 0.04 | ||||||
Loss on investment | � | � | � | 3.1 | � | 3.1 | 0.06 | ||||||
Other project and related costs | � | (1.7) | 1.7 | 1.7 | 0.3 | 1.4 | 0.03 | ||||||
Total Adjusted Non-GAAP | $ 289.8 | $ 105.1 | $ 94.8 | $ 77.7 | $ 16.5 | $ 61.2 | $ 1.22 | ||||||
GAAP as a percent of net sales | 44.3% | 17.0% | 12.8% | GAAP effective tax rate | 21.6% | ||||||||
Adjusted as a percent of net sales | 44.7% | 16.2% | 14.6% | Adjusted effective tax rate | 21.2% |
(1) EBIT is defined as Earnings before Income taxes. |
Nine months ended June 30, 2025 | |||||||||||||
Gross | SG&A | Operating | EBIT (1) | Income | Net | Diluted EPS | |||||||
GAAP � Reported | $ 716.3 | $ 313.0 | $ 132.9 | $ 76.8 | $ 20.8 | $ 56.0 | $ 1.17 | ||||||
Restructuring and related charges | 1.2 | (0.6) | 34.2 | 34.2 | 8.5 | 25.7 | 0.53 | ||||||
Acquisition and integration costs | � | (0.5) | 0.5 | 0.5 | 0.1 | 0.4 | 0.01 | ||||||
Sun Care reformulation costs | � | � | 2.2 | 2.2 | 0.5 | 1.7 | 0.04 | ||||||
Gain on investment | � | � | � | (0.9) | � | (0.9) | (0.02) | ||||||
Commercial realignment | 3.0 | � | 3.0 | 3.0 | 0.9 | 2.1 | 0.04 | ||||||
Vendor bankruptcy | 1.6 | � | 1.6 | 1.6 | 0.4 | 1.2 | 0.02 | ||||||
Other project and related costs | � | (4.4) | 4.4 | 2.9 | 0.6 | 2.3 | 0.05 | ||||||
Total Adjusted Non-GAAP | $ 722.1 | $ 307.5 | $ 178.8 | $ 120.3 | $ 31.8 | $ 88.5 | $ 1.84 | ||||||
Adjusted Non-GAAP Constant Currency | $ 2.13 | ||||||||||||
GAAP as a percent of net sales | 42.5% | 18.6% | 7.9% | GAAP effective tax rate | 27.0% | ||||||||
Adjusted as a percent of net sales | 42.8% | 18.2% | 10.6% | Adjusted effective tax rate | 26.4% | ||||||||
Adjusted Constant Currency as a percent of net sales | 43.7% | 11.5% |
Nine Months Ended June 30, 2024 | |||||||||||||
Gross | SG&A | Operating | EBIT (1) | Income | Net | Diluted EPS | |||||||
GAAP � Reported | $ 742.9 | $ 320.9 | $ 178.9 | $ 115.5 | $ 25.7 | $ 89.8 | $ 1.79 | ||||||
Restructuring and related charges | � | (0.1) | 13.2 | 13.2 | 3.3 | 9.9 | 0.20 | ||||||
Acquisition and integration costs | � | (2.1) | 2.1 | 2.1 | 0.5 | 1.6 | 0.03 | ||||||
Sun Care reformulation costs | � | � | 2.2 | 2.2 | 0.5 | 1.7 | 0.03 | ||||||
Wet Ones manufacturing plant fire | 8.0 | � | 8.0 | 8.0 | 2.0 | 6.0 | 0.12 | ||||||
Legal matter | � | (3.9) | 3.9 | 3.9 | 1.0 | 2.9 | 0.06 | ||||||
Loss on investment | � | � | � | 3.1 | � | 3.1 | 0.06 | ||||||
Other project and related costs | � | (2.9) | 2.9 | 2.9 | 0.7 | 2.2 | 0.04 | ||||||
Total Adjusted Non-GAAP | $ 750.9 | $ 311.9 | $ 211.2 | $ 150.9 | $ 33.7 | $ 117.2 | $ 2.33 | ||||||
GAAP as a percent of net sales | 42.8% | 18.5% | 10.3% | GAAP effective tax rate | 22.2% | ||||||||
Adjusted as a percent of net sales | 43.3% | 18.0% | 12.2% | Adjusted effective tax rate | 22.3% |
(1) EBIT is defined as Earnings before Income taxes. |
Note 3 - Net Sales and Profit by Segment
Operations for the Company are reported via three Segments. The following tables present changes in net sales and segment profit for the three and nine months ended June 30,2025, as compared to the corresponding period in the prior year quarter.
Net Sales | |||||||||||||||
Quarter ended June30, 2025 | |||||||||||||||
Wet Shave | Sun and Skin Care | Feminine Care | Total | ||||||||||||
Net Sales - Q3 2024 | $ 316.3 | $ 256.9 | $ 74.6 | $ 647.8 | |||||||||||
Organic | (5.7) | (1.8)% | (14.1) | (5.5)% | (7.7) | (10.4)% | (27.5) | (4.2)% | |||||||
Impact of currency | 6.4 | 2.0% | 0.6 | 0.2% | (0.1) | (0.1)% | 6.9 | 1.1% | |||||||
Net Sales - Q3 2025 | $ 317.0 | 0.2% | $ 243.4 | (5.3)% | $ 66.8 | (10.5)% | $ 627.2 | (3.2)% |
Net Sales | |||||||||||||||
Nine months ended June 30, 2025 | |||||||||||||||
Wet Shave | Sun and Skin Care | Feminine Care | Total | ||||||||||||
Net Sales - Q3 2024 | $ 911.1 | $ 608.1 | $ 216.9 | ||||||||||||
Organic | (12.2) | (1.3)% | (8.4) | (1.3)% | (22.3) | (10.3)% | (42.9) | (2.5)% | |||||||
Impact of currency | (1.9) | (0.2)% | (4.6) | (0.8)% | (0.4) | (0.2)% | (6.9) | (0.4)% | |||||||
Net Sales - Q3 2025 | $ 897.0 | (1.5)% | $ 595.1 | (2.1)% | $ 194.2 | (10.5)% | (2.9)% |
Segment Profit | |||||||||||||||
Quarter Ended June30, 2025 | |||||||||||||||
Wet Shave | Sun and Skin Care | Feminine Care | Total | ||||||||||||
Segment Profit - Q3 2024 | $ 47.6 | $ 64.2 | $ 6.6 | $ 118.4 | |||||||||||
Organic | 1.1 | 2.3% | (16.9) | (26.3)% | (1.7) | (25.7)% | (17.5) | (14.8)% | |||||||
Impact of currency | (4.6) | (9.7)% | (1.3) | (2.0)% | (0.4) | (6.1)% | (6.3) | (5.3)% | |||||||
Segment Profit - Q3 2025 | $ 44.1 | (7.4)% | $ 46.0 | (28.3)% | $ 4.5 | (31.8)% | $ 94.6 | (20.1)% |
Segment Profit | |||||||||||||||
Nine months ended June 30, 2025 | |||||||||||||||
Wet Shave | Sun and Skin Care | Feminine Care | Total | ||||||||||||
Segment Profit - Q3 2024 | $ 141.7 | $ 117.3 | $ 22.6 | $ 281.6 | |||||||||||
Organic | 7.6 | 5.4% | (19.5) | (16.6)% | (11.3) | (50.0)% | (23.2) | (8.2)% | |||||||
Impact of currency | (12.0) | (8.5)% | (4.4) | (3.8)% | (0.5) | (2.2)% | (16.9) | (6.0)% | |||||||
Segment Profit - Q3 2025 | $ 137.3 | (3.1)% | $ 93.4 | (20.4)% | $ 10.8 | (52.2)% | $ 241.5 | (14.2)% |
For all tables, the impact of currency to segment profit includes both the translational and transactional currency changes during the quarter.
Note 4 - Net Debt and EBITDA
The Company reports financial results on a GAAP and adjusted basis. The tables below are used to reconcile Net Debt and Net earnings to EBITDA and Adjusted EBITDA, which are non-GAAP measures, to improve comparability of results between periods.
June 30, | September 30, | ||
Notes payable | $ 23.2 | $ 24.5 | |
Long-term debt | 1,372.7 | 1,275.0 | |
Gross debt | $ 1,395.9 | $ 1,299.5 | |
Less: Cash and cash equivalents | 199.6 | 209.1 | |
Net debt | $ 1,196.3 | $ 1,090.4 |
Three Months Ended June 30, | Nine Months Ended June 30, | ||||||
2025 | 2024 | 2025 | 2024 | ||||
Net earnings | $ 29.1 | $ 49.0 | $ 56.0 | $ 89.8 | |||
Income tax provision | 8.1 | 13.5 | 20.8 | 25.7 | |||
Interest expense, net | 19.0 | 17.8 | 56.9 | 56.6 | |||
Depreciation and amortization | 22.1 | 21.7 | 65.6 | 66.6 | |||
EBITDA | $ 78.3 | $ 102.0 | $ 199.3 | $ 238.7 | |||
Restructuring and related charges (1) | 17.2 | 3.2 | 33.0 | 13.2 | |||
Acquisition & integration costs | � | 0.7 | 0.5 | 2.1 | |||
Sun Care reformulation costs | 0.5 | 1.3 | 2.2 | 2.2 | |||
Wet Ones manufacturing plant fire | � | 2.7 | � | 8.0 | |||
Legal matter | � | 2.5 | � | 3.9 | |||
(Gain) loss on investment | � | 3.1 | (0.9) | 3.1 | |||
Commercial realignment | (0.1) | � | 3.0 | � | |||
Vendor bankruptcy | 1.2 | � | 1.6 | � | |||
Other project and related costs | (0.7) | 1.7 | 2.9 | 2.9 | |||
Adjusted EBITDA | $ 96.4 | $ 117.2 | $ 241.6 | $ 274.1 | |||
Adjusted EBITDA Constant Currency | $ 104.2 | $ 260.7 | |||||
(1) Excludes |
Note 5 - Outlook
The following tables provide reconciliations of Adjusted EPS and Adjusted EBITDA, Non-GAAP measures, included within the Company's outlook for projected fiscal 2025 results:
Adjusted EPS Outlook | ||
Fiscal 2025 GAAP EPS | approx. | |
Restructuring and related charges | approx. | 0.96 |
Sun Care reformulation costs | approx. | 0.09 |
Commercial realignment | approx. | 0.06 |
Vendor bankruptcy | approx. | 0.04 |
Other costs | approx. | 0.09 |
Income taxes(1) | approx. | (0.32) |
Fiscal 2025 Adjusted EPS Outlook (Non-GAAP) | approx. | 2.65 |
(1) Income tax effect of the adjustments to Fiscal 2025 GAAP EPS noted above. |
Adjusted EBITDA Outlook | ||
Fiscal 2025 GAAP Net Income | approx. | |
Income tax provision | approx. | 10 |
Interest expense, net | approx. | 74 |
Depreciation and amortization | approx. | 88 |
EBITDA | approx. | |
Restructuring and related charges (2) | approx. | 44 |
Sun Care reformulation costs | approx. | 4 |
Commercial realignment | approx. | 3 |
Vendor bankruptcy | approx. | 2 |
Other costs | approx. | 4 |
Fiscal 2025 Adjusted EBITDA | approx. |
(2) Excludes accelerated depreciation, which is included within Depreciation and amortization. |
View original content to download multimedia:
SOURCE Edgewell Personal Care Company